iShares Neuroscience and Healthcare ETF
About
iShares Neuroscience and Healthcare ETF (US46436E3532) is a US-listed equity ETF tracking the NYSE FactSet Global Neuro Biopharma and MedTech Index (USD) (Net). With a expense ratio of 0.47%, its costs are on the higher end for an ETF, paying distributions. The fund holds 86 positions across 9 regions with 5M in assets, with heavy concentration — 72% in United States, 84% in Health Care.
Score Breakdown
Scores are scaled 1–10 on a logarithmic curve relative to all ETFs in the database. Last updated: Jun 22, 2026
| Component | Score | Details |
|---|---|---|
| Cost (30%) | 7.7 | Tracking Difference: 10.0 · TD Consistency: — · Expense Ratio: 2.2 |
| Liquidity (25%) | 2.5 | Assets Under Management |
Data sources: provider factsheets, exchange data, and NAV history. Information for educational purposes only — not investment advice.
Ticker IBRN
ISIN
Fund Size $5.4M
Issuer iShares
Distribution Pays Distributions
Replication Physical
Inception Aug 2022
Base Currency USD
Index NYSE FactSet Global Neuro Biopharma and MedTech Index (USD) (Net)
Asset Class Equities
Costs
7.7 This fund has low total costs, with competitive tracking and expense ratios.
Expense Ratio0.00%
Expense Ratio0.00%
| Metric | Value |
|---|---|
| Expense Ratio | 0.47% |
Cumulative Returns
Performance across different time periods.
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
Inception+0.00%
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
Inception+0.00%
| Period | Cumulative Return |
|---|---|
| 1 Month | — |
| 3 Months | — |
| 6 Months | — |
| 1 Year | +65.10% |
| 3 Years | +14.58% |
| 5 Years | — |
| 10 Years | — |
| YTD | +11.00% |
| Since Inception | +10.17% |
Holdings
This fund invests into 86 individual investments.
View all holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Arrowhead Pharmaceuticals Inc | ARWR | 426.90% |
| 2 | PTC Therapeutics Inc | PTCT | 424.57% |
| 3 | Praxis Precision Medicines Inc | PRAX | 423.77% |
| 4 | Axsome Therapeutics Inc | AXSM | 411.43% |
| 5 | Scholar Rock Holding Corp | SRRK | 407.53% |
| 6 | Alkermes PLC | ALKS | 400.93% |
| 7 | Dianthus Therapeutics Inc | DNTH | 390.81% |
| 8 | Xenon Pharmaceuticals Inc | XENE | 390.12% |
| 9 | CENTESSA PHARMACEUTICALS AMERICAN | CNTA | 386.05% |
| 10 | Biogen Inc | BIIB | 383.94% |
| 11 | ARGENX SE - ADR | ARGX | 375.50% |
| 12 | ACADIA Pharmaceuticals Inc | ACAD | 372.07% |
| 13 | Neurocrine Biosciences Inc | NBIX | 368.33% |
| 14 | Catalyst Pharmaceuticals Inc | CPRX | 356.64% |
| 15 | Denali Therapeutics Inc | DNLI | 353.11% |
| 16 | Edgewise Therapeutics Inc | EWTX | 294.08% |
| 17 | Dyne Therapeutics Inc | DYN | 266.13% |
| 18 | Supernus Pharmaceuticals Inc | SUPN | 245.75% |
| 19 | Axogen Inc | AXGN | 236.12% |
| 20 | SK Biopharmaceuticals Co Ltd | 326030 | 226.69% |
| 21 | Sarepta Therapeutics Inc | SRPT | 180.74% |
| 22 | Biohaven Ltd | BHVN | 173.33% |
| 23 | H Lundbeck A/S | HLUN B | 173.17% |
| 24 | Taysha Gene Therapies Inc | TSHA | 153.70% |
| 25 | Capricor Therapeutics Inc | CAPR | 151.13% |
| 26 | BioArctic AB | BIOA B | 135.77% |
| 27 | Idorsia Ltd | IDIA | 127.22% |
| 28 | Integra LifeSciences Holdings Corp | IART | 118.31% |
| 29 | Rapport Therapeutics Inc | RAPP | 108.14% |
| 30 | Neuren Pharmaceuticals Ltd | NEU | 99.97% |
| 31 | ALTO NEUROSCIENCE INC | ANRO | 72.67% |
| 32 | Annexon Inc | ANNX | 71.10% |
| 33 | Dynavox Group AB | DYVOX | 66.85% |
| 34 | SOLID BIOSCIENCES INC | SLDB | 66.35% |
| 35 | USD CASH | USD | 66.06% |
| 36 | Medincell SA | MEDCL | 65.71% |
| 37 | LB Pharmaceuticals Inc | LBRX | 63.45% |
| 38 | RELMADA THERAPEUTICS INC | RLMD | 58.15% |
| 39 | CLEARPOINT NEURO INC | CLPT | 49.32% |
| 40 | DESIGN THERAPEUTICS INC | DSGN | 47.71% |
| 41 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 46.83% |
| 42 | MICROPORT NEUROTECH CORP | 2172 | 45.29% |
| 43 | CERIBELL INC | CBLL | 44.84% |
| 44 | BRAINSWAY ADR REPRESENTING LTD | BWAY | 44.70% |
| 45 | PROTHENA PLC | PRTA | 42.09% |
| 46 | ONCOLYS BIOPHARMA INC | 4588 | 41.86% |
| 47 | NEUROPACE INC | NPCE | 40.64% |
| 48 | BENITEC BIOPHARMA INC | BNTC | 40.63% |
| 49 | NEUROGENE INC | NGNE | 39.76% |
| 50 | OVID THERAPEUTICS INC | OVID | 38.71% |
Sectors
Allocation by industry sector.
| Sector | Weight |
|---|---|
| Health Care | 8414.00% |
| Unknown | 1519.00% |
| Technology | 67.00% |
Regions
Geographic allocation by country of risk.
| Country | Weight |
|---|---|
| United States | 7172.00% |
| UNKNOWN | 1518.00% |
| Netherlands | 376.00% |
| South Korea | 227.00% |
| Sweden | 203.00% |
| Denmark | 173.00% |
| Switzerland | 127.00% |
| Australia | 100.00% |
| France | 66.00% |
| Japan | 38.00% |
Feedback
ETFs
Basket
Compare